Literature DB >> 18480971

Renal artery stenosis: comparative evaluation of gadolinium-enhanced MRA and DSA.

F Stacul1, S Gava, M Belgrano, S Cernic, L Pagnan, F Pozzi Mucelli, M A Cova.   

Abstract

PURPOSE: This study was undertaken to evaluate the accuracy of contrast-enhanced magnetic resonance angiography (CE-MRA) in detecting renal artery stenosis using intra-arterial digital subtraction angiography (DSA) as the gold standard.
MATERIALS AND METHODS: Thirty-five consecutive patients with possible renovascular hypertension were prospectively studied; 26 of them underwent both MRA and DSA. In these 26 cases, two readers assessed the number of renal arteries, the presence of stenoses and their degree. Results were compared with DSA, and sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and diagnostic accuracy of MRA were determined. Interobserver variability was also calculated.
RESULTS: DSA showed 51 main renal arteries (one patient had a single kidney) and six accessory arteries (total number of arteries 57) in the 26 patients considered. Both MRA readers detected all of the 51 main renal arteries and only one accessory vessel. When the presence of stenosis was considered, the readers' results, respectively, were as follows: sensitivity 77% and 72%, specificity 69% and 69%, PPV 86% and 85%, NPV 55% and 50% and diagnostic accuracy 75% and 71%. When the detection of significant stenosis was considered, the results, respectively, were: sensitivity 83% and 83%, specificity 73% and 78%, PPV 60% and 65%, NPV 90% and 91%, and diagnostic accuracy 76% and 80%. Interobserver variation was good when considering stenosis detection (kappa=0.69) and excellent when considering detection of significant stenosis (kappa=0.85).
CONCLUSIONS: MRA results do not appear as positive as in the majority of papers in the literature. Multiple reasons can probably be invoked to explain this difference. The mean age of our patients, higher than in many other studies, should be noted and may have accounted for their possible poor cooperation. Moreover, all of the missed significant stenoses were distally located, and therefore, the failure to detect them might be related to the suboptimal spatial resolution of MRA. Nevertheless, MRA showed a high NPV for detecting significant stenoses, a finding of considerable clinical relevance in that it allows patients with normal MRA findings to be spared additional more invasive procedures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480971     DOI: 10.1007/s11547-008-0270-9

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  56 in total

1.  Morphologic and functional magnetic resonance imaging of renal artery stenosis: a multireader tricenter study.

Authors:  Stefan O Schoenberg; Michael V Knopp; Frank Londy; Sumati Krishnan; Ivan Zuna; Nicole Lang; Marco Essig; Hans Hawighorst; Jeffrey H Maki; David Stafford-Johnson; Friedrich Kallinowski; Thomas L Chenevert; Martin R Prince
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

2.  Assessment of gadolinium-enhanced time-resolved three-dimensional MR angiography for evaluating renal artery stenosis.

Authors:  H Masunaga; Y Takehara; H Isoda; T Igarashi; M Sugiyama; S Isogai; N Kodaira; H Takeda; A Nozaki; H Sakahara
Journal:  AJR Am J Roentgenol       Date:  2001-05       Impact factor: 3.959

3.  3D MR angiography of renal arteries: comparison of volume rendering and maximum intensity projection algorithms.

Authors:  Ammar Mallouhi; Michael Schocke; Werner Judmaier; Christian Wolf; Andreas Dessl; Benedikt V Czermak; Peter Waldenberger; Werner R Jaschke
Journal:  Radiology       Date:  2002-05       Impact factor: 11.105

Review 4.  Multiple detector-row CT angiography of the renal and mesenteric vessels.

Authors:  Dominik Fleischmann
Journal:  Eur J Radiol       Date:  2003-03       Impact factor: 3.528

5.  A prospective study of disease progression in patients with atherosclerotic renal artery stenosis.

Authors:  R E Zierler; R O Bergelin; R C Davidson; K Cantwell-Gab; N L Polissar; D E Strandness
Journal:  Am J Hypertens       Date:  1996-11       Impact factor: 2.689

6.  Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features.

Authors:  M R Prince; S O Schoenberg; J S Ward; F J Londy; T W Wakefield; J C Stanley
Journal:  Radiology       Date:  1997-10       Impact factor: 11.105

7.  Noninvasive diagnosis of renal artery stenosis by ultrasonic duplex scanning.

Authors:  T R Kohler; R E Zierler; R L Martin; S C Nicholls; R O Bergelin; A Kazmers; K W Beach; D E Strandness
Journal:  J Vasc Surg       Date:  1986-11       Impact factor: 4.268

8.  [Accuracy of CT angiography in the diagnosis of renal artery stenosis].

Authors:  M Galanski; M Prokop; A Chavan; C Schaefer; K Jandeleit; C Olbricht
Journal:  Rofo       Date:  1994-12

9.  Natural history of atherosclerotic renal artery stenosis associated with aortic disease.

Authors:  D F Tollefson; C B Ernst
Journal:  J Vasc Surg       Date:  1991-09       Impact factor: 4.268

10.  Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography.

Authors:  M R Prince; E K Yucel; J A Kaufman; D C Harrison; S C Geller
Journal:  J Magn Reson Imaging       Date:  1993 Nov-Dec       Impact factor: 4.813

View more
  3 in total

1.  Off-label use of intravascular iodinated organic and MR contrast media.

Authors:  O Tamburrini; I Aprile; C Falcone; D Console; A Rotundo; A Rotondo
Journal:  Radiol Med       Date:  2010-10-27       Impact factor: 3.469

2.  Non-invasive imaging cannot replace formal angiography in the diagnosis of renovascular hypertension.

Authors:  Agnes Trautmann; Derek J Roebuck; Clare A McLaren; Eileen Brennan; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2016-10-17       Impact factor: 3.714

Review 3.  Imaging in the evaluation of renovascular disease.

Authors:  Kjell Tullus; Derek J Roebuck; Clare A McLaren; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2009-10-24       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.